Hong Kong-based BioMed Technology Holdings, which engages in microbiome research and development, has snapped $2 million in an oversubscribed seed financing round from Alibaba Hong Kong Entrepreneurs Fund (AEF), Gobi Partners GBA, and The International Medical, according to a company release last week.
The firm plans to use the proceeds on R&D as well as expansion into mainland China and Asia, per the release.